ABCB1 and Miyoshi myopathy: In myeloma patients and MM cell lines, treatments with classic chemotherapeutic drugs, such as doxorubicin and melphalan, have been reported to upregulate ABCB1 expression, which contributes to the development of resistance to these drugs (198).